Efficacy of factor VIII/von Willebrand factor concentrate Alphanate ® in preventing excessive bleeding during surgery in subjects with von Willebrand disease

G. E. Rivard, L. Aledort

Research output: Contribution to journalArticlepeer-review

36 Scopus citations

Abstract

The adequacy of perioperative haemostasis with a high-purity, plasma-derived factor VIII product containing von Willebrand factor was retrospectively evaluated in 39 patients with type 1, 2 or 3 von Willebrand disease who underwent 61 major or minor surgical or invasive procedures. Overall, 93.5% of the responses to treatment were rated as excellent or good by the physician investigators. These ratings were confirmed by an independent panel of physician referees.

Original languageEnglish
Pages (from-to)271-275
Number of pages5
JournalHaemophilia
Volume14
Issue number2
DOIs
StatePublished - Mar 2008

Keywords

  • Factor VIII
  • Invasive procedures
  • Surgery
  • Von Willebrand disease
  • Von Willebrand factor

Fingerprint

Dive into the research topics of 'Efficacy of factor VIII/von Willebrand factor concentrate Alphanate ® in preventing excessive bleeding during surgery in subjects with von Willebrand disease'. Together they form a unique fingerprint.

Cite this